ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0400

Is There Any Influence of Gender on the Sociodemographic and Clinical Characteristics of Psoriatic Arthrithis?

Brian Manases roldan1, Carolina A Isnardi2, Virginia Carrizo Abarza1, Maria Agustina Alfaro1, Tatiana Barbich2, Maria Gisela Crespo Rocha2, Marina Fornaro2, Osvaldo Luis Cerda2, Fernando Dal pra2, Emilce Edith Schneeberger2 and Gustavo Citera2, 1Rheumatology Unit, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 2Instituto de Rehabilitación Psicofísica (IREP), Buenos Aires, Argentina

Meeting: ACR Convergence 2022

Keywords: Psoriatic arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, and Outcomes Poster I

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: To evaluate the differences in sociodemographic and clinical characteristics, disease activity, functional status and quality of life between male and female patients with PsA.

Methods: Observational cross-sectional study. Patients of≥18 years old with a diagnosis of PsA according to CASPAR criteria were included. Sociodemographic, clinical and therapeutic characteristics, comorbidities, toxic habits and extra-articular manifestations were collected. Presence of dactylitis and enthesitis (MASES) were recorded. Cutaneous psoriasis was assessed by PASI, BSA and nail involvement by PNSS. ESR (mm/h) and CRP (mg/dl) values were recorded. HAQ-A questionnaires for functional capacity and PsAQoL and DLQI for quality of life were administered. Composite indices were calculated: DAPSA and DAPSA-ESR. Additionally, the presence of MDA was determined. Axial involvement was defined by ASAS 2009 criteria. X-rays were read by 3 experienced rheumatologists (CCI: ≥ 0.89) according to Sharp van der Heijde index. Statistical descriptive analysis: Chi² and Fisher’s exact test, Student’s t-test, Mann Whitney, ANOVA and multiple logistic regression.

Results: A total of 170 patients were included, 50% female, mean (X) age 54.5±13.5 years and mean disease duration was 11.4±9.7 years. Most patients had only peripheral involvement, 88.2% in men and 83.5% in women.Sharp/van der Heijde score was higher in men than in women but this difference was not significant (men X 43.1±75.4 vs women X 37.1±55.8, p=NS).

Regarding disease activity, females presented a higher frequency of enthesitis (31.2% vs 16.5%, p=< 0.0001) and higher DAPSA-ERS (X 17.9±11.9 vs X 14.5±10.5, p=0.048), while males had higher skin involvement (BSA X 6.5±14.3 vs X 3±15.3, p=0.032). Moreover, no significant differences were found in functional capacity (HAQ-A men X 0.92±0.7 vs women 0.72±10.5) and quality of life (PsAQoL men X 6.4±6.5 vs women X 7.2±6.4).

In multivariate analysis, adjusting for age and disease duration, males presented higher skin involvement by BSA (OR 1.05, 95%CI 1.01-1.1), while MASES was lower in this group (OR 0.8, 95%CI 0.73-0.98, p= 0.03).

Conclusion: Women had higher disease activity and entheseal involvement, while men presented greater extension of psoriasis.The entheseal involvement and psoriasis remained significantly associated with gender after adjusting for sociodemographic and clinical variables.


Disclosures: B. roldan, None; C. Isnardi, None; V. Carrizo Abarza, None; M. Alfaro, None; T. Barbich, None; M. Crespo Rocha, None; M. Fornaro, None; O. Cerda, None; F. Dal pra, Pfizer, Abbvie; E. Schneeberger, AbbVie/Abbott, Pfizer, Boehringer-Ingelheim, Janssen, Bristol-Myers Squibb(BMS); G. Citera, AbbVie, Amgen, Bristol Myers Squibb, Gema, Janssen, Pfizer, Sandoz, Boehringer Ingelheim.

To cite this abstract in AMA style:

roldan B, Isnardi C, Carrizo Abarza V, Alfaro M, Barbich T, Crespo Rocha M, Fornaro M, Cerda O, Dal pra F, Schneeberger E, Citera G. Is There Any Influence of Gender on the Sociodemographic and Clinical Characteristics of Psoriatic Arthrithis? [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/is-there-any-influence-of-gender-on-the-sociodemographic-and-clinical-characteristics-of-psoriatic-arthrithis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-there-any-influence-of-gender-on-the-sociodemographic-and-clinical-characteristics-of-psoriatic-arthrithis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology